150 related articles for article (PubMed ID: 17409826)
1. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer.
Nagai S; Takenaka K; Sonobe M; Ogawa E; Wada H; Tanaka F
J Thorac Oncol; 2006 Jan; 1(1):46-51. PubMed ID: 17409826
[TBL] [Abstract][Full Text] [Related]
2. MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer.
Kaira K; Okumura T; Nakagawa K; Ohde Y; Takahashi T; Murakami H; Naito T; Endo M; Kondo H; Nakajima T; Yamamoto N
Pathol Oncol Res; 2012 Apr; 18(2):439-47. PubMed ID: 21964914
[TBL] [Abstract][Full Text] [Related]
3. Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non-small cell lung cancer.
Kaira K; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Endo M; Kondo H; Nakajima T; Yamamoto N
Int J Surg Pathol; 2012 Jun; 20(3):223-32. PubMed ID: 22108499
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
6. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
7. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
9. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer.
Yu CJ; Yang PC; Shun CT; Lee YC; Kuo SH; Luh KT
Int J Cancer; 1996 Dec; 69(6):457-65. PubMed ID: 8980247
[TBL] [Abstract][Full Text] [Related]
11. Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.
Lappi-Blanco E; Mäkinen JM; Lehtonen S; Karvonen H; Sormunen R; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Kaarteenaho R
Tumour Biol; 2016 Oct; 37(10):13811-13820. PubMed ID: 27481516
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
[TBL] [Abstract][Full Text] [Related]
13. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
Tanaka F; Otake Y; Nakagawa T; Kawano Y; Miyahara R; Li M; Yanagihara K; Inui K; Oyanagi H; Yamada T; Nakayama J; Fujimoto I; Ikenaka K; Wada H
Cancer Res; 2001 Feb; 61(4):1666-70. PubMed ID: 11245481
[TBL] [Abstract][Full Text] [Related]
16. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer.
Lee YC; Wu CT; Kuo SW; Tseng YT; Chang YL
Chest; 2007 Apr; 131(4):993-9. PubMed ID: 17426201
[TBL] [Abstract][Full Text] [Related]
17. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
18. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
19. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
[TBL] [Abstract][Full Text] [Related]
20. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
